NASDAQ: GCTK
Glucotrack Inc Stock

$0.61-0.03 (-4.69%)
Updated Feb 10, 2025
GCTK Price
$0.61
Fair Value Price
$1.03
Market Cap
$174.89k
52 Week Low
$0.49
52 Week High
$99.00
P/E
-0.01x
P/B
-0.04x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$14.92M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.21
Operating Cash Flow
-$11M
Beta
0.42
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

GCTK Overview

GlucoTrack, Inc., a medical device company, develops non-invasive glucose monitoring devices for people suffering from diabetes and pre-diabetics. Known as Integrity Applications, Inc. until 2021/11, GlucoTrack was founded in 2001 and is based in Or Yehuda, Israel.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine GCTK's potential to beat the market

FStrong Sell
  • Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More

Zen Rating Component Grades

F
Value
D
Growth
F
Momentum
C
Sentiment
C
Safety
D
Financials
F
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical

Industry Rating
A
GCTK
Ranked
#49 of 49

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$8.12A
$33.25A
$4.65A
View Top Medical Stocks

Be the first to know about important GCTK news, forecast changes, insider trades & much more!

GCTK News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how GCTK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GCTK ($0.61) is undervalued by 41.43% relative to our estimate of its Fair Value price of $1.03 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
GCTK ($0.61) is significantly undervalued by 41.43% relative to our estimate of its Fair Value price of $1.03 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
GCTK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GCTK due diligence checks available for Premium users.

Valuation

GCTK fair value

Fair Value of GCTK stock based on Discounted Cash Flow (DCF)

Price
$0.61
Fair Value
$1.03
Undervalued by
41.04%
GCTK ($0.61) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GCTK ($0.61) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GCTK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GCTK price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.01x
Industry
40.12x
Market
31x

GCTK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-0.04x
Industry
4.11x

GCTK's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.1M
Profit Margin
0%
GCTK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$826.0k
Liabilities
$4.8M
Debt to equity
-1.21
GCTK's short-term liabilities ($4.61M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GCTK's short-term assets ($642.00k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GCTK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
GCTK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.1M
Investing
-$33.0k
Financing
$4.4M
GCTK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GCTK vs Medical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
GCTKF$174.89k-5.75%-0.01x-0.04x
STSS$616.64k+3.63%-0.04x0.09x
AVGR$1.53M+22.45%-0.05x0.40x
MHUA$8.28M+5.17%0.89x0.06x
BNGOF$8.87M-10.62%-0.04x0.18x

Glucotrack Stock FAQ

What is Glucotrack's quote symbol?

(NASDAQ: GCTK) Glucotrack trades on the NASDAQ under the ticker symbol GCTK. Glucotrack stock quotes can also be displayed as NASDAQ: GCTK.

If you're new to stock investing, here's how to buy Glucotrack stock.

What is the 52 week high and low for Glucotrack (NASDAQ: GCTK)?

(NASDAQ: GCTK) Glucotrack's 52-week high was $99.00, and its 52-week low was $0.49. It is currently -99.39% from its 52-week high and 24.95% from its 52-week low.

How much is Glucotrack stock worth today?

(NASDAQ: GCTK) Glucotrack currently has 288,601 outstanding shares. With Glucotrack stock trading at $0.61 per share, the total value of Glucotrack stock (market capitalization) is $174.89k.

Glucotrack stock was originally listed at a price of $8,125.00 in Apr 25, 2013. If you had invested in Glucotrack stock at $8,125.00, your return over the last 11 years would have been -99.99%, for an annualized return of -57.85% (not including any dividends or dividend reinvestments).

How much is Glucotrack's stock price per share?

(NASDAQ: GCTK) Glucotrack stock price per share is $0.61 today (as of Feb 10, 2025).

What is Glucotrack's Market Cap?

(NASDAQ: GCTK) Glucotrack's market cap is $174.89k, as of Feb 11, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Glucotrack's market cap is calculated by multiplying GCTK's current stock price of $0.61 by GCTK's total outstanding shares of 288,601.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.